著作: Takaesu Y/Watanabe K/[沼田 周助]/Iwata M/Kudo N/Oishi S/Takizawa T/Nemoto K/Yasuda Y/Tagata H/Tsuboi T/Tsujino N/Hashimoto N/Matsui Y/Hori H/Yamamori H/Sugiyama N/Suwa T/Kishimoto T/Hishimoto A/Usami M/Furihata R/Iwamoto K/Fujishiro H/Nakamura T/Mizuno K/Inagaki T/Katsumoto E/Tomita H/Ohi K/Muraoka H/Atake K/Iida H/Nagasawa T/Fujita J/Yamamura S/Onitsuka T/Murata A/Takayanagi Y/Noda H/Matsumura Y/Takezawa K/[伊賀 淳一]/Ichihashi K/Ogasawara K/Yamada H/Inada K/Hashimoto R/Improvement of psychiatrists' clinical knowledge of the treatment guidelines for schizophrenia and major depressive disorders using the 'Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)' project: A nationwide dissemination, education, and evaluation study./[Psychiatry and Clinical Neurosciences]
(英) Improvement of psychiatrists' clinical knowledge of the treatment guidelines for schizophrenia and major depressive disorders using the 'Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)' project: A nationwide dissemination, education, and evaluation study.
(英) Although treatment guidelines for pharmacological therapy for schizophrenia and major depressive disorder have been issued by the Japanese Societies of Neuropsychopharmacology and Mood Disorders, these guidelines have not been well applied by psychiatrists throughout the nation. To address this issue, we developed the 'Effectiveness of Guidelines for Dissemination and Education in Psychiatric Treatment (EGUIDE)' integrated education programs for psychiatrists to disseminate the clinical guidelines. Additionally, we conducted a systematic efficacy evaluation of the programs. Four hundred thirteen out of 461 psychiatrists attended two 1-day educational programs based on the treatment guidelines for schizophrenia and major depressive disorder from October 2016 to March 2018. We measured the participants' clinical knowledge of the treatment guidelines using self-completed questionnaires administered before and after the program to assess the effectiveness of the programs for improving knowledge. We also examined the relation between the participants' demographics and their clinical knowledge scores. The clinical knowledge scores for both guidelines were significantly improved after the program. There was no correlation between clinical knowledge and participant demographics for the program on schizophrenia; however, a weak positive correlation was found between clinical knowledge and the years of professional experience for the program on major depressive disorder. Our results provide evidence that educational programs on the clinical practices recommended in guidelines for schizophrenia and major depressive disorder might effectively improve participants' clinical knowledge of the guidelines. These data are encouraging to facilitate the standardization of clinical practices for psychiatric disorders.
Psychiatry and Clinical Neurosciences([社団法人 日本精神神経学会])
|年月日||必須||2019年 10月 初日|